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Intestinal pseudo-obstruction is a massive colonic dilation with signs and symptoms of colonic obstruction, 
but without a mechanical cause. A 49-year-old female patient complained of nausea, vomiting, and abdominal 
distension 1 month after a massive brainstem hemorrhage. No improvement was seen with conservative 
treatments. An extended-length rectal tube was inserted to perform glycerin enema. In addition, bethanechol 
(35 mg per day) was administered to stimulate colonic motility. Th   e patient’s condition gradually improved over 
a 2-month period without any surgical intervention. Extended length rectal tube enema and bethanechol can be 
used to improve intestinal pseudo-obstruction in stroke patients.
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INTRODUCTION
Intestinal pseudo-obstruction is an intestinal obstruc-
tion symptom that occurs due only to movement disorder 
without intestinal mechanical stricture; the main cause 
in patients with brain lesions is known to be extrinsic au-
tonomic nervous system abnormality.
1 In stroke patients, 
air-fl  uid levels cannot be observed, and its vague physical 
signs and symptoms, intestinal pseudo-obstruction can 
be incorrectly diagnosed as a simple case of constipation 
and lead to a delay of correct diagnosis. Simple consti-
pation is common and occurs in 55% of stroke patients 
during the initial 4-weeks after stroke, and can be caused 
by bed rest, medications, dehydration, and dysphagia.
2 
Unlike constipation, intestinal pseudo-obstruction is a 
serious ailment that can lead to complications such as 
megacolon, bowel perforation, peritonitis, and sepsis,
3 
and except for intravenous injection of neostigmine, the 
eff  ectiveness of conservative treatments is limited. Here, 
we report a case where the condition of a patient with 
intestinal pseudo-obstruction due to extrinsic autonomic 
nervous system abnormality that was caused by brain-
stem hemorrhage showed improvement with the use of 
bethanechol without surgery, by inserting and leaving an 
extended-length rectal tube in the patient and repeatedly 
conducting decompressions and enemas.
CASE REPORT
A 49-year-old female patient visited the department 
of rehabilitation 1 month after suffering a cerebellar 
Received August 24, 2010; Accepted May 30, 2011
Corresponding author: In-hun Na
Department of Rehabilitation Medicine, Daejeon St. Mary’s Hospital, Th  e 
Catholic University of Korea, 520-2, Daeheung-dong, Jung-gu, Daejeon 
301-723, Korea
Tel: +82-42-220-9650, Fax: +82-42-252-6807, E-mail: nih81@naver.com
   This is an open-access article distributed under the terms of the 
Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0) which permits unrestricted 
noncommercial use,   distribution,   and reproduction in any medium, 
  provided the original work is properly cited.
Copyright © 2012 by Korean Academy of Rehabilitation MedicineIntestinal Pseudo-obstruction in a Brainstem Hemorrhage Patient
279 www.e-arm.org
hemorrhage (Fig. 1) affecting more than two thirds of 
her anterior ventral of pons on both sides, midbrain, 
and medullar right of cerebellum. The upper and lower 
extremity strengths were MRC (medical research coun-
cil) right 2 and left 0-1, and there was ataxia on her right 
side. The patient was able to communicate by blinking 
her eyes, had limb and facial paralysis, dysarthria, dys-
phagia, sweating disorder, and had a Levin tube and the 
urinary catheter installed. She had a body temperature 
of 36.5
oC, pulse of 82 beats/min, and average blood pres-
sure of 140/80 mmHg, which was not well controlled. 
Before visiting the hospital, the patient hadn’t had bowel 
movement for more than 7 days and she complained of 
nausea, vomiting, and abdominal pain. She was experi-
encing abdominal distension, but abdominal tenderness 
and rebound tenderness were not observed, and had low 
bowel sounds. In a plain radiograph, the colon and small 
intestine were fi  lled with gas and feces, and the ascend-
ing colon’s diameter was increased to 95 mm (Fig. 2). On 
computed tomography, there were no tumors or vascular 
abnormalities that would cause mechanical obstruction 
in the intestinal tract, and there wasn’t any endoscopic 
finding in the stomach. The blood tests showed hemo-
globin (11.8 g/dl), leukocytes (9,500/mm
3), ESR (54), and 
CRP (0.88). In biochemical tests including an electrolyte-
specific test; there were no specific findings. A Clos-
tridium diffi   cile toxin test was negative. Although fasting, 
fluid therapy, bowel stimulant, intestinal massage, and 
glycerin enema using an installed rectal tube were con-
ducted, none of these procedures were eff  ective. Starting 
on day 9 after admission, glycerin enema was conducted 
using a 170 cm extended-length rectal tube. Th  e  extend-
ed-length rectal tube was inserted with 4 French 45 cm 
rubber intestinal tubes overlapped 5 cm with one anoth-
er and wound with Tegaderm
TM (Healthcare, 3M). At 1-2 
day intervals, enemas were repeatedly administered for 
2 weeks. However, after 2 weeks, enemas were done less 
often and yet the oral dietary food intake was increased, 
hence, the symptoms worsened. Erythromycin (500 mg) 
was orally administered 4 times daily and the patient 
showed rapid improvement of symptoms, but due to the 
increased oral dietary food intake, nausea, vomiting, 
and gas distension were observed. To ease the condition, 
metoclopramide (10 mg) was intravenously injected 2 
times daily and erythromycin was changed to bethan-
echol and administered. Bethanechol was administered 
at a starting dose of 5 mg, and then increased to 3 times 
daily or a total of more than 30 mg, along with a 1-2 times 
weekly enemas using the extended-length rectal tube, 
and regular stool movement was possible. After enemas, 
the extended-length rectal tube was forced out along with 
feces, and regular rectal tubes were then used. Common 
side effects of bethanechol such as sweating, flushing, 
and hypotension were not observed, and the dosage was 
reduced to 35 mg and maintained after observing drool-
ing of saliva at a dose of 40 mg. After 1 month of treat-
Fig. 1. Brain MRI of the patient (2 months after onset) shows 
massive brainstem hemorrhage involving area from midbrain, 
pons to cerebellum in axial T2 weighted FLAIR image.
Fig. 2. Plain radiograph of a patient shows fecal impaction 
and marked gaseous dilatation in large and small bowel. 
Maximum diameter in ascending colon was 95 mm.Sang-jee Lee, et al.
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ments starting from the 75
th day after the fi  rst admission, 
the patient’s symptoms did not worsen even without the 
use of rectal tubes. At 3 months after the fi  rst admission, 
stool movement was possible by using bisacodyl (20 mg) 
once every 2-3 days. After 9 months, when the patient was 
re-admitted for rehabilitation treatment, her right-side 
muscle strength was grade 3. And there was an improve-
ment of dysphagia suffi   cient for her to swallow porridge. 
She was able to urinate by herself and there was frequent 
urination. When her amount of exercise was reduced, al-
though bowel obstruction symptoms such as gas bloating 
were observed during abdominal radiography, they were 
easily improved after a daylong use of rectal tubes and 
treatment with magnesium hydroxide, mosapride, and 
bisacodyl suppositories.
DISCUSSION
Occurrences of intestinal pseudo-obstruction can be 
divided into 2 groups: causes of which are central and ex-
trinsic autonomic nervous system anomalies of the cen-
tral nervous system
1,3 such as stroke, spinal cord injury, 
Parkinson’s disease, multiple sclerosis, and Alzheimer’s 
disease; and peripheral causes such as diabetes which in-
vades the plexus.
1 Based on analyses of 400 cases of intes-
tinal pseudo-analysis, because the majority of cases were 
accompanied by complications such as infections includ-
ing pneumonia and sepsis, surgery, metabolic diseases, 
cancer, respiratory ailment, renal failure, myocardial in-
farction, and heart failure, intestinal pseudo-obstruction 
could not infer information from admitted patients in the 
rehabilitation medicine department with these compli-
cations.
4 Th   e regions of the brain involved with control of 
the extrinsic autonomic nervous system are the prefron-
tal cortex, red nucleus of the stria terminalis, hypotha-
lamic nucleus, nucleus of the amygdala, and medullar.
5 
In this study, the movement of the upper splenic fl  exure 
of the intestinal tract was reduced because of medullary 
lesions where the nucleus of the vagus nerve and nerves 
are located. The cause of intestinal pseudo-obstruction 
was a loss of parasympathetic nerve response or hyperac-
tivity of parasympathetic nerve response due to an auto-
nomic nervous system control anomaly.
3 Th   ere is a previ-
ous report with fi  ndings of intestinal obstructions similar 
to those of this case caused by medullary lesions.
6 The 
symptoms included abdominal pain, vomiting, bowel 
obstruction, diarrhea due to bacterial proliferation, and 
steatorrhea.
3 In cases where bowel perforation occurs, 
the mortality rate reaches 40%,
4 but could not be distin-
guished by the symptoms only; tenderness was acute and 
accompanied by heat, or the white cell increase rate was 
higher, and special attention is required when the cecum 
diameter is more than 12 cm because this increases the 
possibility.
3,7 Treatment is to adjust the electrolyte level 
anomaly by using a fl  uid therapy, and stop medications 
such as anticholinergic drugs, narcotics, and calcium 
channel blockers which reduce intestinal movement.
1 
For patients incapable of walking, it helps to have them 
grab their knees with their hands and change postures.
7 
Medicinal treatments for pseudo-obstruction include 
erythromycin, cisapride, neostigmine, bethanechol, 
octreotide, and domperidone. Although erythromycin, 
other than its antibiotic benefits, can affect the moti-
lin receptor and promote intestinal tract movement,
1,6,8 
treatment eff  ects on the distal are limited because the re-
ceptor exists proximal to the terminal ileal.
8 Octreotide is 
a sustained-release somatostatin which promotes intesti-
nal tract movement and blocks germ growth in the small 
intestine.
1,8 Neostigmine has been proven to be eff  ective 
in a randomized-blinded study.
8 When conservative 
treatment has limitations, a slow intravenous injection 
of neostigmine (2 mg) is recommended, during which 
the monitoring of electrocardiogram, blood pressure, 
and hemodynamics are needed.
3 We chose bethanechol, 
which can be administered orally, rather than a fast-act-
ing intravenous injection medication for the patient with 
Fig. 3. Extended length rectal tube was inserted up to sigmoid 
colon with improvement of pseudo-obstruction.Intestinal Pseudo-obstruction in a Brainstem Hemorrhage Patient
281 www.e-arm.org
damaged control of the autonomous nervous system. 
Bethanechol is a drug that acts on the muscarinic recep-
tor when it becomes hyperactive and acts on the bladder 
and abdominal organs. It is clinically similar to neostig-
mine, and is an agonist of the parasympathetic nerve, but 
induces partial contraction instead of promoting intesti-
nal tract movement.
8 Although there are reports of cases 
with subcutaneous injection of 10 mg, there are no writ-
ten reports concerning oral administration of neostig-
mine.
9 In the case report of this study, there was clinical 
improvement from continuing to administer regular ene-
mas with bethanechol. When there was no improvement 
after administering medication, even though a pressure 
reduction procedure through colon endoscopy could be 
conducted, this was proven to be technically difficult, 
and a 1-5% occurrence rate of intestinal perforation com-
plication was reported.
7 In the case where an endoscope 
could not be utilized, there was report of improvement 
when a 140 cm extended-length rectal tube was used 
along with enema fl  uid.
10 Although rectal tubes without 
the inducing power may become bent or experience dif-
ficulty going through the bends in the intestines, there 
is a low risk of sustaining perforated intestine and they 
don’t require specialized skills. First, feces and intestinal 
gases in the lower intestinal tract are removed, and then 
the next insertion can penetrate slightly deeper into the 
upper part of intestine, which helps when conducting 
endoscopy.
3 In this case study, the location of the rectal 
tube was verifi  ed to be near the top of the sigmoid colon 
bend (Fig. 3). Ostomy, a surgical procedure done under 
radiological guidance, is feasible;
3 in a case where intes-
tinal ischemia and intestinal perforation are of concern. 
Th   e damaged part of the rectal tract can be removed and 
decompression procedures such as ostomy or cecostomy 
can be conducted.
5 Although the underlying disease that 
reduced intestinal tract movement is not resolved by sur-
gery, ostomy and cecostomy can improve nausea, vomit-
ing and abdominal distension, and are effective means 
for delivering nutrition to the intestinal tract. However, 
the risk of recurrence and worsening of stroke must be 
understood by patients with acute stroke. Th   is case study 
has discussed literature regarding intestinal pseudo-ob-
struction. It is being reported because improvement was 
made by the rehabilitation department using relatively 
safe and easy methods.
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